BioCentury | Feb 15, 2016
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or Akiva, Israel Business: Musculoskeletal Date completed: 2016-02-08 Type: Venture financing Raised: $15 million Investors: Haisco; Medica Venture Partners; SCP Vitalife Partners; Generali Investment; Technion Investment Opportunities Fund WIR Staff Musculoskeletal...
BioCentury | Sep 30, 2013
Clinical News

GelrinC implant: Phase I/II data

...International Cartilage Repair Society meeting in Izmir. GelrinC has CE Mark approval in the EU. Regentis Biomaterials Ltd....
BioCentury | May 21, 2012
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or-Akiva, Israel Business: Musculoskeletal Date completed: 5/14/12 Type: Venture financing Raised: $10 million Investors: Royal DSM N.V. ; Crossroad Fund; Medica Venture Partners; SCP Vitalife Partners; Technion Investment Opportunities Fund WIR Staff...
Items per page:
1 - 3 of 3
BioCentury | Feb 15, 2016
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or Akiva, Israel Business: Musculoskeletal Date completed: 2016-02-08 Type: Venture financing Raised: $15 million Investors: Haisco; Medica Venture Partners; SCP Vitalife Partners; Generali Investment; Technion Investment Opportunities Fund WIR Staff Musculoskeletal...
BioCentury | Sep 30, 2013
Clinical News

GelrinC implant: Phase I/II data

...International Cartilage Repair Society meeting in Izmir. GelrinC has CE Mark approval in the EU. Regentis Biomaterials Ltd....
BioCentury | May 21, 2012
Financial News

Regentis Biomaterials completes venture financing

Regentis Biomaterials Ltd. , Or-Akiva, Israel Business: Musculoskeletal Date completed: 5/14/12 Type: Venture financing Raised: $10 million Investors: Royal DSM N.V. ; Crossroad Fund; Medica Venture Partners; SCP Vitalife Partners; Technion Investment Opportunities Fund WIR Staff...
Items per page:
1 - 3 of 3